Company intelligence / Profile preview
Amdis Healthsciences
- Ownership
- Private
- Development stage
- Other
Overview
The company manufactures and markets a wide range of niche generics, nutraceuticals, and bioactive formulations. It has launched products in both India and the GCC (Gulf Cooperation Council) region, with strong distribution in South India and recent expansion into the UAE. Specific clinical trial data is not disclosed.
- Therapeutic areas
- GastroenterologyWomen's HealthRheumatologyOther
- Modalities
- Small moleculeNutraceuticalMedical deviceBiologic
- Industry
- Biotech
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Amdis Healthsciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Amdis Healthsciences.